ONESOURCE SPECIALTY PHARMA
Back to Cashflow Statement
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹412 Cr | ₹-391 Cr | ₹118 Cr | ₹1,162 Cr |
What is the latest Cash Flow from Financing Activities ratio of ONESOURCE SPECIALTY PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹412 Cr |
| Mar2024 | ₹-391 Cr |
| Mar2023 | ₹118 Cr |
| Mar2022 | ₹1,162 Cr |
How is Cash Flow from Financing Activities of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹412 Cr | Positive | |
| Mar2024 | ₹-391 Cr | Negative | |
| Mar2023 | ₹118 Cr | -89.82 | |
| Mar2022 | ₹1,162 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹17,800.9 Cr | -1.5% | -5.8% | -16% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,675.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,516.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,190.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹115,523.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,493.4 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | -1.5% |
-5.8% |
-16% |
| SENSEX | -1% |
0.7% |
-3.6% |
You may also like the below Video Courses